Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus

Clinical Rheumatology

Volumn 21, Issue 3, 2002, Pages 251-254

  Cheng, Tien Tsai ^a   Chiu, Chun Kai ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Homocysteine; Raynaud's phenomenon; Systemic lupus erythematosus

Indexed keywords

HOMOCYSTEINE; PREDNISOLONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PREMENOPAUSE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RAYNAUD DISEASE; REFERENCE VALUES;

EID: 0036062523     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-8291-6     Document Type: Article

References (18)

1. Vitamin B12, vitamin B6 and folate nutritional status in men with hyperhomocysteinemia
2. Plasma homocysteine in renal failure
3. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis
4. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women
5. Venodilatation in Raynaud's disease
6. Homocysteine theory of arteriosclerosis
7. Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
8. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
9. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: A retrospective cohort study
10. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
11. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention
12. Elevated homocysteine levels in patients with Raynaud's syndrome
13. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon
14. Symptoms of RP in an inner-city African-American community: Prevalence and self-reported cardiovascular comorbidity
15. Abnormal homocysteine metabolism in rheumatoid arthritis
16. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate
17. New approach to the treatment of Raynaud's phenomenon